|
Immunall Science Inc. (GNS) -
| Industry: | Consumer Products and Services |
| RSP Eligible: | Yes |
| Market Maker: | No Market Maker |
 |
   
|
|||||||||||||||||||||||||||||||||||||||
 |
|||||
| Date/Time | Price | Change | Volume | Buyer | Seller |
| Apr 04, 14:25 | 0.005 | 0.000 | 100,000 | BMO Nesbitt | CIBC |
| Nov 27, 12:22 | 0.005 | 0.000 | 1,000 | RBC | Qtrade |
| Oct 15, 14:28 | 0.005 | -0.095 | 28,000 | Anonymous | TD Securities |
| Oct 15, 14:28 | 0.005 | -0.095 | 2,000 | RBC | TD Securities |
| Oct 09, 14:59 | 0.100 | +0.095 | 2,000 | RBC | RBC |
 |
|
| Issued & Outstanding: | 42,265,842 |
| Reserved for Issuance: | 0 |
| Thin Float: | Yes |
|
||||||||||||||||||||
|
||||||||||||||||||||
CNSX announced today a new strategic partnership with Innovate Calgary and Alberta Deal Generator (ADG). Innovate Calgary and CNSX have forged a partnership agreement to enhance and support the technology and startup sector in Canada.
>>>
>>>
CNSX Markets Inc. (“CNSX” or the “Exchange”) completed the second tranche of a financing, the first part of which was announced on December 17, 2012.
>>>
>>>
ALP-Final Assay Results
5/17/2013
5/17/2013
RSS-RESAAS to Attend MRED - May 17, 2013
5/17/2013
5/17/2013